Comments on: Fred Hassan: Savvy Bargain Hunter? http://www.pharmalot.com/2008/04/fred-hassan-savvy-bargain-hunter/ News, Comment and Conversation Fri, 10 Feb 2012 19:08:11 +0000 http://wordpress.org/?v=2.6.2 By: Disgusted http://www.pharmalot.com/2008/04/fred-hassan-savvy-bargain-hunter/#comment-349725 Disgusted Tue, 06 May 2008 23:46:10 +0000 http://www.pharmalot.com/2008/04/fred-hassan-savvy-bargain-hunter/#comment-349725 Information just reported on "Shearlings got Plowed" blog regarding Fred Hassan's recent stock award is absolutely obscene. And they say that entertainers and ballplayers aren't worth what they get paid! What about a CEO that gets rewarded with outrageous amounts of stock for laying off 10% or more of his employees? Big Pharma capitalism is a joke! These guys are squeezing every little drop of blood out of the turnip before the party ends. Information just reported on “Shearlings got Plowed” blog regarding Fred Hassan’s recent stock award is absolutely obscene. And they say that entertainers and ballplayers aren’t worth what they get paid! What about a CEO that gets rewarded with outrageous amounts of stock for laying off 10% or more of his employees? Big Pharma capitalism is a joke! These guys are squeezing every little drop of blood out of the turnip before the party ends.

]]> By: rainnn http://www.pharmalot.com/2008/04/fred-hassan-savvy-bargain-hunter/#comment-312236 rainnn Thu, 24 Apr 2008 18:35:42 +0000 http://www.pharmalot.com/2008/04/fred-hassan-savvy-bargain-hunter/#comment-312236 Heh -- synchronicity, it seems. We each had the same thought, at about the same time. . . . I do wonder whether the "non-disclosure" of the "known trends. . . and uncertainties" (re the $700M fall-off at the Merck/Schering J/V equity income line for 2008, averred by Dick Clark on Monday, and denied by Hassan on Wednesday), will ultimately pose a problem for Mr. Hassan: Was all the information he "knew" made publicly-available -- when he bought? 'Tis perplexing, indeed. Great post, Ed! Heh — synchronicity, it seems.

We each had the same thought, at about the same time. . . .

I do wonder whether the “non-disclosure” of the “known trends. . . and uncertainties” (re the $700M fall-off at the Merck/Schering J/V equity income line for 2008, averred by Dick Clark on Monday, and denied by Hassan on Wednesday), will ultimately pose a problem for Mr. Hassan:

Was all the information he “knew” made publicly-available — when he bought?

‘Tis perplexing, indeed.

Great post, Ed!

]]>